Chemoinformaics analysis of alpha-Santalyl acetate
| Molecular Weight | 262.393 | nRot | 5 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 25 |
| Exact Molecular Weight | 262.193 | nRing | 4 |
| Solubility: LogS | -4.72 | nHRing | 0 |
| Solubility: LogP | 3.843 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 47.3306 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.621 |
| Synth | 5.089 |
| Natural Product Likeliness | 2.781 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.132 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.696 |
| MDCK | 0.0000152 |
| BBB | 0.945 |
| PPB | 0.816745 |
| VDSS | 0.95 |
| FU | 0.128891 |
| CYP1A2-inh | 0.035 |
| CYP1A2-sub | 0.265 |
| CYP2c19-inh | 0.049 |
| CYP2c19-sub | 0.959 |
| CYP2c9-inh | 0.08 |
| CYP2c9-sub | 0.121 |
| CYP2d6-inh | 0.805 |
| CYP2d6-sub | 0.721 |
| CYP3a4-inh | 0.875 |
| CYP3a4-sub | 0.861 |
| CL | 18.464 |
| T12 | 0.147 |
| hERG | 0.033 |
| Ames | 0.009 |
| ROA | 0.252 |
| SkinSen | 0.062 |
| Carcinogencity | 0.817 |
| EI | 0.009 |
| Respiratory | 0.981 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.644462 |